NO961906L - Fremgangsmåte ved fremstilling av et klodronatpreparat - Google Patents

Fremgangsmåte ved fremstilling av et klodronatpreparat

Info

Publication number
NO961906L
NO961906L NO961906A NO961906A NO961906L NO 961906 L NO961906 L NO 961906L NO 961906 A NO961906 A NO 961906A NO 961906 A NO961906 A NO 961906A NO 961906 L NO961906 L NO 961906L
Authority
NO
Norway
Prior art keywords
clodronate
pct
preparation
tetrahydrate
disodium
Prior art date
Application number
NO961906A
Other languages
English (en)
Other versions
NO961906D0 (no
NO312938B1 (no
Inventor
Esko Pohjala
Heikki Nupponen
Kari Lehmussaari
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO961906D0 publication Critical patent/NO961906D0/no
Publication of NO961906L publication Critical patent/NO961906L/no
Publication of NO312938B1 publication Critical patent/NO312938B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Glass Compositions (AREA)
  • Seasonings (AREA)
  • Glanulating (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
NO19961906A 1993-11-12 1996-05-10 Fremgangsmåte ved fremstilling av et klodronatpreparat NO312938B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (fi) 1993-11-12 1993-11-12 Menetelmä klodronaattivalmisteen valmistamiseksi
PCT/FI1994/000509 WO1995013054A1 (en) 1993-11-12 1994-11-11 Process for preparing a clodronate preparation

Publications (3)

Publication Number Publication Date
NO961906D0 NO961906D0 (no) 1996-05-10
NO961906L true NO961906L (no) 1996-05-23
NO312938B1 NO312938B1 (no) 2002-07-22

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961906A NO312938B1 (no) 1993-11-12 1996-05-10 Fremgangsmåte ved fremstilling av et klodronatpreparat

Country Status (25)

Country Link
US (1) US5776499A (no)
EP (1) EP0727983B1 (no)
JP (1) JPH09504800A (no)
KR (1) KR100352155B1 (no)
CN (1) CN1040945C (no)
AT (1) ATE202700T1 (no)
AU (1) AU679586B2 (no)
CA (1) CA2175994A1 (no)
CZ (1) CZ286132B6 (no)
DE (1) DE69427648T2 (no)
DK (1) DK0727983T3 (no)
ES (1) ES2160688T3 (no)
FI (1) FI94926C (no)
GR (1) GR3036470T3 (no)
HU (1) HU220633B1 (no)
IL (1) IL111596A (no)
NO (1) NO312938B1 (no)
NZ (1) NZ275833A (no)
PL (1) PL176658B1 (no)
PT (1) PT727983E (no)
RU (1) RU2141323C1 (no)
SK (1) SK280552B6 (no)
TW (1) TW436297B (no)
WO (1) WO1995013054A1 (no)
ZA (1) ZA948974B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro) 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
CN108472703B (zh) * 2015-12-22 2021-01-01 切佩茨基机械厂股份公司 使用钛合金制造棒材的方法
US11654153B2 (en) 2017-11-22 2023-05-23 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-MAF status
TWI806467B (zh) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 金融商品提昇報酬率多維度決策方法
IT202300007269A1 (it) 2023-04-14 2024-10-14 Univ Degli Studi Magna Graecia Di Catanzaro Formulazione farmaceutica composta da Peptide-C associato a un bisfosfonato in forma unica e suo uso nel trattamento dell’osteosarcopenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
BR9307859A (pt) * 1993-05-15 1996-01-09 Boehringer Mannheim Gmbh Comprimido com biodisponibilidade aperfeiçoada que contérn ácido

Also Published As

Publication number Publication date
AU679586B2 (en) 1997-07-03
WO1995013054A1 (en) 1995-05-18
US5776499A (en) 1998-07-07
CZ286132B6 (cs) 2000-01-12
FI94926C (fi) 1995-11-27
TW436297B (en) 2001-05-28
ES2160688T3 (es) 2001-11-16
IL111596A0 (en) 1995-01-24
GR3036470T3 (en) 2001-11-30
ZA948974B (en) 1995-11-21
ATE202700T1 (de) 2001-07-15
AU8108794A (en) 1995-05-29
SK280552B6 (sk) 2000-03-13
EP0727983A1 (en) 1996-08-28
DE69427648T2 (de) 2002-04-18
KR960705548A (ko) 1996-11-08
CZ132796A3 (en) 1996-10-16
HU9601257D0 (en) 1996-07-29
NO961906D0 (no) 1996-05-10
FI935019L (fi) 1995-05-13
DE69427648D1 (de) 2001-08-09
RU2141323C1 (ru) 1999-11-20
PL314299A1 (en) 1996-09-02
JPH09504800A (ja) 1997-05-13
FI94926B (fi) 1995-08-15
CN1040945C (zh) 1998-12-02
HUT75228A (en) 1997-04-28
HU220633B1 (hu) 2002-03-28
PT727983E (pt) 2001-11-30
FI935019A0 (fi) 1993-11-12
NO312938B1 (no) 2002-07-22
IL111596A (en) 1998-12-06
CN1134664A (zh) 1996-10-30
EP0727983B1 (en) 2001-07-04
SK60696A3 (en) 1997-02-05
CA2175994A1 (en) 1995-05-18
KR100352155B1 (ko) 2002-12-31
PL176658B1 (pl) 1999-07-30
DK0727983T3 (da) 2001-09-24
NZ275833A (en) 1997-10-24

Similar Documents

Publication Publication Date Title
GR3031936T3 (en) Process for preparing controlled release pharmaceutical forms and the forms thus obtained.
GR3035219T3 (en) New active principle-containing microparticles, agents containing the same, their use for the ultrasonically controlled release of active principles, and process for preparing the same
UA37214C2 (uk) Таблетки, що диспергуються у воді, та спосіб їх виготовлення
DK0777964T3 (da) Fremgangsmåde til fremstilling af et doseringssystem
MY104772A (en) Dispersible granules of fungicidal products.
IL115309A0 (en) Pharmaceutical preparation containing metformin and processes for the production thereof
DK0789559T3 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
MY136231A (en) Slow release compositions
NO961906D0 (no) Fremgangsmåte ved fremstilling av et klodronatpreparat
HUT44128A (en) Process for producing substituted pyrimidines and pesticide compositions containing them as active components
HUT45694A (en) Herbicide and growth-controllong compositions containing 5-amino-1-phenyl-pyrazoles as active components and process for producing the active components
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
GB2124078B (en) Processes for preparing tablets by a modified wet-granulation technique
JPS5296729A (en) Mixed vaccin for cyanomycosis
ES2113408T3 (es) Procedimiento para preparar una composicion detergente granular.
FR2703262B1 (fr) Mélanges gazeux.
JPS53122679A (en) Process for preparing forming tablets
DK260387D0 (da) Soenderdelingsapparat til tilvejebringelse af pastaagtige masser, isaer poelsemasse
JPS5432487A (en) Preparation of 1-carbamoyluracils
JPS53103441A (en) Preparation of optical active phenylglycines
JPS55160715A (en) Tablet having improved disintegrating property
HUT52781A (en) Process for producing new isomeres of dideoxynucleosides and pharmaceutical compositions containing them as active components
RU94018502A (ru) Способ получения гербицидных гранулированных продуктов
UA6826A (uk) Кристалічний фосфат акваамінкобальту /п/ та спосіб його одержання
PT74192A (en) Process for the preparation of o,o-dimethyl-2,2,2-trichloro-1-(tetrahidropyranil-2-oxy)-ethylphosphotrichloro- -1-hydroxy-1-(pyranyl-2-oxy)-ethylphoaphonate and of insectici-dal compositions having a nate and of insecticidal compositions having a syssystemic action in animals temic action on animals